Effect of mequitazine on the pharmacokin
β
T. Hasegawa; K. Takagi; T. Kuzuya; M. Nadai; R. Apichartpichean; I. Muraoka
π
Article
π
1990
π
Springer
π
English
β 398 KB
The effect of an oral anti-allergic drug, mequitazine, on the pharmacokinetics of theophylline has been investigated in seven asthmatic patients. They received chronic theophylline therapy (a sustained-release theophylline tablet 200-400 mg b.d. at 12 h intervals) and coadministered mequitazine 6 mg